Open Therapeutics LLC, today announced that Jason E. Barkeloo, Chief Executive Officer, will present at the BIO Investor Forum in San Francisco, October 20, 2015, at 2:30 p.m. Pacific Time in the Balboa room.
__________________
About Open Therapeutics
A synthetic biology biotechnology company with a focus on developing and crowdsourcing innovative open drug candidates for cancers and antibiotics.
